NDC 52257-1002-1 - ATOMY BB CREAM SPF 30 PA
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 52257-1002
- Requested NDC
- 52257-1002-1
- Package NDCs from labels
- 52257-1002-1, 52257-1002-2
- Manufacturer
- ATOMY CO LTD
- Effective date
- 2010-04-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ATOMY BB CREAM SPF 30 PA - ATOMY CO LTD | ATOMY CO LTD | 2010-04-29 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 52257-1002-2 | 2020-11-04 | C162847 | 48780-1 | 956f9ecf-c9ab-621f-e053-dbdaa90a74ad | ATOMY BB CREAM SPF 30+PA++ |
| 52257-1002-2 | 2019-10-21 | C162847 | 48780-1 | 956f9ecf-c9ab-621f-e053-dbdaa90a74ad | ATOMY BB CREAM SPF 30+PA++ |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| OCTINOXATE | ACTIVE INGREDIENT | 4Y5P7MUD51 | ATOMY BB CREAM SPF 30 PA (OCTINOXATE) CREAM [ATOMY CO LTD] | 2 | |
| TITANIUM DIOXIDE | ACTIVE INGREDIENT | 15FIX9V2JP | ATOMY BB CREAM SPF 30 PA (OCTINOXATE) CREAM [ATOMY CO LTD] | 2 | |
| ZINC OXIDE | ACTIVE INGREDIENT | SOI2LOH54Z | ATOMY BB CREAM SPF 30 PA (OCTINOXATE) CREAM [ATOMY CO LTD] | 2 | |
| OCTINOXATE | ACTIVE MOIETY | 4Y5P7MUD51 | ATOMY BB CREAM SPF 30 PA (OCTINOXATE) CREAM [ATOMY CO LTD] | 2 | |
| TITANIUM DIOXIDE | ACTIVE MOIETY | 15FIX9V2JP | ATOMY BB CREAM SPF 30 PA (OCTINOXATE) CREAM [ATOMY CO LTD] | 2 | |
| ZINC OXIDE | ACTIVE MOIETY | SOI2LOH54Z | ATOMY BB CREAM SPF 30 PA (OCTINOXATE) CREAM [ATOMY CO LTD] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.